Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Jan 12 2026
Oct 17 2025
Sep 3 2025
Apr 24 2025
Dec 27 2025